POTASSIUM CITRATE EXTENDED RELEASE
NDC 42543-408, POTASSIUM CITRATE, tablet, from Strides Pharma Inc..
- Product NDC
- 42543-408
- Status
- Listed
- Labeler
- Strides Pharma Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206813
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42543-408 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POTASSIUM CITRATE15 meq/1
Pharmacologic classes
Acidifying Activity [MoA]; Anti-coagulant [EPC]; Calcium Chelating Activity [MoA]; Calculi Dissolution Agent [EPC]; Decreased Coagulation Factor Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42543-408-01 | 42543040801 | 100 TABLET in 1 BOTTLE (42543-408-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/5f38b02c-703c-4fc2-b833-654e41bd617fNADAC price for package 42543040801
GET /v1/drugs/nadac/42543040801
Use it
Look up 42543-408 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42543-408 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42543-408. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.